Live Breaking News & Updates on Armed Immunocytokine Platform

Stay updated with breaking news from Armed immunocytokine platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SunHo Announces First Patient Dosed in Phase 1/2 Clinical Trial of Two First-in-class Immunocytokines: IAP0971 and IAE0972

/PRNewswire/ SunHo BioPharmaceutical Co., Ltd. ("SunHo"), a clinical-stage leading biopharma in immunocytokines with full-set of capabilities from discovery. ....

China Biopharmaceutical Co Ltd , European Medicines Agency , Drug Administration , Sunho Biopharmaceutical Co Ltd , China National Medicinal Products Administration , Liusong Yin , Executive President , Chief Science Officer , Armed Immunocytokine , Armed Immunocytokine Platform , Armed Innate Effector Multispecific Platform , Antibody Platform , National Medicinal Products Administration , Sunho China Biopharmaceutical Co , Biotechnology , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Clinical Trials Amp Medical Discoveries ,